812 Followers on Owler

4DMT

is a California-based biotechnology company that researches and develops gene therapeutics for the treatment of eye, liver and heart diseases... Read more
OverviewCompetitorsFundingNews & Insights

4DMT

is a California-based biotechnology company that researches and develops gene therapeutics for the treatment of eye, liver and heart diseases... Read more
4DMT Co-Founder & CEO: David Kirn

Co-Founder & CEO

David Kirn

CEO Approval Rating

90/100

2013

PublicNASDAQFDMT

Pharmaceuticals & Biotechnology
Biotechnology
8000 NAICS listing

Annual Revenue
$88.3M
Employees
120
Funding
$617.8M

News

Funding
Nov 06, 2025
GlobeNewswire
4DMT received $100M in Post-IPO Equity Funding

4DMT Competitors

1Regeneron
2AGTC
3Sanofi
4Takeda Pharmaceutical
5Protalix
6Amicus Therapeutics
7Freeline
8Spark Therapeutics
9Renova Therapeutics
10BioMarin
Unlock 15 + competitors

Trending Companies